Literature DB >> 26397443

The Analgesic Efficacy of Ultrasound-Guided Transversus Abdominis Plane Block in Adult Patients: A Meta-Analysis.

Moira Baeriswyl1, Kyle R Kirkham, Christian Kern, Eric Albrecht.   

Abstract

BACKGROUND: Previous meta-analyses of the transversus abdominis plane (TAP) block have examined a maximum of 12 articles, including fewer than 650 participants, and have not examined the effect of ultrasound-guided techniques specifically. Recently, many trials that use ultrasound approaches to TAP block have been published, which report conflicting analgesic results. This meta-analysis aims to evaluate the analgesic efficacy of ultrasound-guided TAP blocks exclusively for all types of abdominal surgeries in adult patients.
METHODS: This meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines. The primary outcome was cumulative IV morphine consumption at 6 hours postoperatively, analyzed according to the type of surgery, the type of surgical anesthesia, the timing of injection, the block approach adopted, and the presence of postoperative multimodal analgesia. Secondary outcomes included IV morphine consumption at 24 hours postoperatively; pain scores at rest and on movement at 6 and 24 hours postoperatively; and postoperative nausea and vomiting, pruritus, and rates of complications.
RESULTS: Thirty-one controlled trials including 1611 adult participants were identified. Independent of the type of surgery (abdominal laparotomy, abdominal laparoscopy, and cesarean delivery) but not independent of the type of surgical anesthesia (general anesthesia, spinal anesthesia with or without intrathecal long-acting opioid), ultrasound-guided TAP block reduced IV morphine consumption at 6 hours postoperatively by a mean difference of 6 mg (95% confidence interval [CI], -7 to -4 mg; I2 = 94%; P < 0.00001). The magnitude of the reduction in morphine consumption at 6 hours postoperatively was not influenced by the timing of injection (I2 = 0%; P = 0.72), the block approach adopted (I2 = 0%; P = 0.72), or the presence of postoperative multimodal analgesia (I2 = 73%; P = 0.05). This difference persisted at 24 hours postoperatively (mean difference, -11 mg; 95% CI, -14 to -8 mg; I2 = 99%; P < 0.00001). Pain scores at rest and on movement were reduced at 6 hours postoperatively (mean difference at rest, -10; 95% CI, -15 to -5; I2 = 92%; P = 0.0002; mean difference on movement, -9; 95% CI, -14 to -5; I2 = 58%; P < 0.00001). There were neither differences in the incidence of postoperative nausea and vomiting (I2 = 1%; P = 0.59) nor in the pruritus (I2 = 12%; P = 0.58) Two minor complications (1 bruise and 1 anaphylactoid reaction) were reported in 1028 patients.
CONCLUSIONS: Ultrasound-guided TAP block provides marginal postoperative analgesic efficacy after abdominal laparotomy or laparoscopy and cesarean delivery. However, it does not provide additional analgesic effect in patients who also received spinal anesthesia containing a long-acting opioid. The minimal analgesic efficacy is independent of the timing of injection, the approach adopted, or the presence of postoperative multimodal analgesia. Because of heterogeneity of the results, these findings should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26397443     DOI: 10.1213/ANE.0000000000000967

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  51 in total

1.  Subcostal Transversus Abdominis Plane Block for Laparoscopic Sleeve Gastrectomy, Is It Worth the Time?

Authors:  Mümin Coşkun; Samet Yardimci; Mustafa Kemal Arslantaş; Gülbin Töre Altun; Tevfik Kıvılcım Uprak; Yalçın Burak Kara; Asim Cingi
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

Review 2.  Abdominal wall blocks for intra-abdominal surgery.

Authors:  D N Onwochei; J Børglum; A Pawa
Journal:  BJA Educ       Date:  2018-09-01

Review 3.  [Peripheral truncal blocks-Overview and assessment].

Authors:  T Steinfeldt; P Kessler; O Vicent; U Schwemmer; J Döffert; P Lang; D Mathioudakis; E Hüttemann; W Armbruster; S Sujatta; M Lange; S Weber; F Reisig; R Hillmann; T Volk; T Wiesmann
Journal:  Anaesthesist       Date:  2020-12       Impact factor: 1.041

4.  Transversus abdominis plane block compared with wound infiltration for postoperative analgesia following Cesarean delivery: a systematic review and network meta-analysis.

Authors:  Pervez Sultan; Selina D Patel; Sandra Jadin; Brendan Carvalho; Stephen H Halpern
Journal:  Can J Anaesth       Date:  2020-10-09       Impact factor: 5.063

Review 5.  [Regional anesthesia - are the standards changing?]

Authors:  T Volk; C Kubulus
Journal:  Anaesthesist       Date:  2017-12       Impact factor: 1.041

6.  Postoperative analgesic efficiency of transversus abdominis plane block after ventral hernia repair: a prospective, randomized, controlled clinical trial.

Authors:  Ion Chesov; Adrian Belîi
Journal:  Rom J Anaesth Intensive Care       Date:  2017-10

Review 7.  American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients.

Authors:  Christopher L Wu; Adam B King; Timothy M Geiger; Michael C Grant; Michael P W Grocott; Ruchir Gupta; Jennifer M Hah; Timothy E Miller; Andrew D Shaw; Tong J Gan; Julie K M Thacker; Michael G Mythen; Matthew D McEvoy
Journal:  Anesth Analg       Date:  2019-08       Impact factor: 5.108

8.  Continuous Transversus Abdominis Plane Blocks via Laparoscopically Placed Catheters for Bariatric Surgery.

Authors:  Alfred M Said; Hany A Balamoun
Journal:  Obes Surg       Date:  2017-10       Impact factor: 4.129

Review 9.  Practical Regional Anesthesia Guide for Elderly Patients.

Authors:  Carole Lin; Curtis Darling; Ban C H Tsui
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

Review 10.  Prevention and Treatment of Chronic Postsurgical Pain: A Narrative Review.

Authors:  Arnaud Steyaert; Patricia Lavand'homme
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.